Figure 1From: Improved functionality, health related quality of life and decreased burden of disease in patients with ADHD treated with OROS® MPH: is treatment response different between children and adolescents?Mean Conners' Parent Rating Scale (CPRS) scores: overall (n = 822) and age subgroups. Data are presented for the intention-to-treat analysis, last observation carried forward. Lower scores denote improvement. Baseline to week 12 improvements were p < 0.0001 for all groups (Wilcoxon test). Assessments at week 6 are only based on data from 224 patients.Back to article page